No abstract available
Keywords:
Clinical trial endpoints; Immunotherapy; Ovarian cancer; Patient reported outcomes; Rare tumors; Regulatory approval.
MeSH terms
-
Carcinoma, Ovarian Epithelial
-
Clinical Trials as Topic / methods*
-
Endpoint Determination / methods*
-
Female
-
Humans
-
Neoplasms, Glandular and Epithelial / therapy*
-
Ovarian Neoplasms / therapy*
-
Patient Reported Outcome Measures
-
United States
-
United States Food and Drug Administration